HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne Fogli Selected Research

Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)

1/2013A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
12/2009Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
8/2009Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
8/2006Peptidomics and proteomics studies of transformed lymphocytes from patients mutated for the eukaryotic initiation factor 2B.
10/2005Dominant form of vanishing white matter-like leukoencephalopathy.
10/2004Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure.
7/2004Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
6/2003Ovarian failure related to eukaryotic initiation factor 2B mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne Fogli Research Topics

Disease

6Glioma (Gliomas)
04/2022 - 02/2016
6Neoplasms (Cancer)
01/2021 - 02/2016
3Ataxia (Dyssynergia)
12/2009 - 07/2004
3Leukoencephalopathies
10/2005 - 06/2003
2Inflammation (Inflammations)
04/2022 - 12/2020
2Vanishing White Matter Leukodystrophy with Ovarian Failure
10/2004 - 07/2004
1Alzheimer Disease (Alzheimer's Disease)
10/2022
1Prostatic Neoplasms (Prostate Cancer)
12/2020
1Brain Neoplasms (Brain Tumor)
10/2019
1Atherosclerosis
07/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2013
1Inborn Genetic Diseases (Disease, Hereditary)
08/2006
1Primary Ovarian Insufficiency
10/2004

Drug/Important Bio-Agent (IBA)

8Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA
01/2013 - 06/2003
4Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2006
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2022 - 10/2019
2Long Noncoding RNAIBA
04/2022 - 03/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2017
1Biomarkers (Surrogate Marker)IBA
10/2022
1Transcription Factors (Transcription Factor)IBA
04/2022
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2020
1Liver X ReceptorsIBA
12/2020
1AndrogensIBA
12/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2017
1Messenger RNA (mRNA)IBA
02/2016
1O(6)-Methylguanine-DNA MethyltransferaseIBA
02/2016
1Lipoproteins (Lipoprotein)IBA
07/2014
1LipidsIBA
07/2014
1Indicators and Reagents (Reagents)IBA
07/2014
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
10/2005
1Peptide Initiation Factors (Initiation Factor)IBA
07/2004

Therapy/Procedure

1Therapeutics
12/2020
1Drug Therapy (Chemotherapy)
02/2016
1Radiotherapy
02/2016